Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

Trial ID or NCT#

NCT01336803

Status

not recruiting iconNOT RECRUITING

Purpose

This pilot trial studies the differentiation of bone sarcomas and osteomyelitis with ferumoxytol-enhanced magnetic resonance imaging (MRI). Imaging procedures that allow doctors to more accurately differentiate between malignant bone sarcomas and osteomyelitis may help in diagnosing patients correctly and may result in more timely treatment.

Official Title

Pilot Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

Eligibility Criteria

Ages Eligible for Study: 10 to 21
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Age 10 to 21 years* Suspected or confirmed diagnosis of a bone sarcoma or osteomyelitis* Informed consent with assent as appropriate.
    1. EXCLUSION CRITERIA
  2. * Contraindication to MRI* Presence of metal implants* Need for sedation or anesthesia* Claustrophobia* Hemosiderosis or hemochromatosis* History of allergic reactions to similar compounds will be obtained and patients with positive history of allergic reactions will be excluded from the study* Females who are pregnancy or nursing
Exclusion Criteria:
  1. * Contraindication to MRI* Presence of metal implants* Need for sedation or anesthesia* Claustrophobia* Hemosiderosis or hemochromatosis* History of allergic reactions to similar compounds will be obtained and patients with positive history of allergic reactions will be excluded from the study* Females who are pregnancy or nursing
View All Criteria
Show Less

Investigator(s)

Heike Daldrup-Link
Heike Daldrup-Link
Pediatric radiologist
Professor of Radiology (General Radiology) and, by courtesy, of Pediatrics (Hematology/Oncology)
Neyssa Marina

Contact us to find out if this trial is right for you.

Contact

Brittney Williams
650-736-3688

View on ClinicalTrials.gov